These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability. Zhang X; Zhang T; Lan Y; Wu B; Shi Z AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778 [TBL] [Abstract][Full Text] [Related]
25. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole. Taupitz T; Dressman JB; Buchanan CM; Klein S Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048 [TBL] [Abstract][Full Text] [Related]
26. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924 [TBL] [Abstract][Full Text] [Related]
27. Alternative oral exemestane formulation: improved dissolution and permeation. Yavuz B; Bilensoy E; Vural I; Sumnu M Int J Pharm; 2010 Oct; 398(1-2):137-45. PubMed ID: 20678561 [TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations. Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543 [TBL] [Abstract][Full Text] [Related]
29. Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes. Ai F; Ma Y; Wang J; Li Y Iran J Pharm Res; 2014; 13(4):1115-23. PubMed ID: 25587299 [TBL] [Abstract][Full Text] [Related]
30. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin. Choi HG; Kim DD; Jun HW; Yoo BK; Yong CS Drug Dev Ind Pharm; 2003 Nov; 29(10):1085-94. PubMed ID: 14677769 [TBL] [Abstract][Full Text] [Related]
31. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes. Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617 [TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes. Sri KV; Kondaiah A; Ratna JV; Annapurna A Drug Dev Ind Pharm; 2007 Mar; 33(3):245-53. PubMed ID: 17454057 [TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
35. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin. Ribeiro A; Figueiras A; Santos D; Veiga F AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116 [TBL] [Abstract][Full Text] [Related]
36. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems. Veiga F; Fernandes C; Maincent P Drug Dev Ind Pharm; 2001 Jul; 27(6):523-32. PubMed ID: 11548859 [TBL] [Abstract][Full Text] [Related]
37. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems. Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117 [TBL] [Abstract][Full Text] [Related]
38. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds. Patel R; Purohit N AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735 [TBL] [Abstract][Full Text] [Related]
39. Direct compression tablets containing a series of four beta-cyclodextrin complexes formed by neutralizing an acidic drug. Moore E; Bergamo R; Casella R Drug Dev Ind Pharm; 2000 Dec; 26(12):1259-70. PubMed ID: 11147126 [TBL] [Abstract][Full Text] [Related]
40. Formulation and In-vitro Evaluation of Orally Disintegrating Tablets of Olanzapine-2-Hydroxypropyl-β-Cyclodextrin Inclusion Complex. Ajit Shankarrao K; Dhairysheel Mahadeo G; Pankaj Balavantrao K Iran J Pharm Res; 2010; 9(4):335-47. PubMed ID: 24381598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]